The Brazilian medicines regulator, Anvisa, has granted temporary emergency use authorization (EUA) to Janssen Pharmaceutical Cos.’ coronavirus vaccine, Ad26.COV2-S. It has also received a second emergency use request for Russia’s Sputnik V vaccine after the first was sent back to the applicant for more information in January.
Anvisa has approved manufacturing facilities for both of the vaccines. However, it refused good manufacturing practice (GMP) certification for the...







